These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6765530)
1. Insulin allergy treated with human insulin (recombinant DNA). De Leeuw I; Delvigne C; Bekaert J Diabetes Care; 1982; 5 Suppl 2():168-70. PubMed ID: 6765530 [TBL] [Abstract][Full Text] [Related]
2. Desensitization with human (recombinant DNA) insulin. Bodendorfer TW; Brown ME; Frankel EH; Palay BH; Fulp SR Drug Intell Clin Pharm; 1985 Nov; 19(11):827-9. PubMed ID: 3905321 [TBL] [Abstract][Full Text] [Related]
3. Intradermal desensitization with human insulin (recombinant DNA) in a patient with severe allergic skin reaction due to insulin. Bachmann W; Hasche H; Mehnert H Diabetes Care; 1982; 5 Suppl 2():165-7. PubMed ID: 6765529 [TBL] [Abstract][Full Text] [Related]
4. Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study. Beyer J; Enzmann F; Lauerbach M; Althoff P; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Haas R Diabetes Care; 1982; 5 Suppl 2():140-8. PubMed ID: 6765526 [TBL] [Abstract][Full Text] [Related]
5. Treatment of allergy to heterologous monocomponent insulin with human semisynthetic insulin. Long-term study. Bruni B; Barolo P; Blatto A; Carlini M; Ansaldi SG; Grassi G Diabetes Care; 1988 Jan; 11(1):59-62. PubMed ID: 3276478 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the activity profiles of two fixed combinations of regular/NPH human insulin (recombinant DNA) of different compositions with a fixed regular/NPH porcine insulin combination (PPI) in insulin-dependent diabetic individuals. Sailer D; Ludwig T; Kolb S Diabetes Care; 1982; 5 Suppl 2():57-9. PubMed ID: 6765542 [TBL] [Abstract][Full Text] [Related]
8. Systemic allergic reaction to initial insulin therapy in a juvenile diabetic. Enhanced blast transformation to insulin. Dacou-Voutetakis C; Thomaidis T; Roma E; Kalpini-Mavrou A; Economou-Mavrou C Acta Paediatr Scand; 1975 Sep; 64(5):773-6. PubMed ID: 1166797 [TBL] [Abstract][Full Text] [Related]
9. Protamine allergy as a complication of insulin hypersensitivity: A case report. Bollinger ME; Hamilton RG; Wood RA J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):462-5. PubMed ID: 10452772 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of NPH human insulin (recombinant DNA) and pork insulin in diabetic subjects: preliminary report. Mirouze J; Monnier L; Richard JL; Gancel A; Soua KB Diabetes Care; 1982; 5 Suppl 2():60-2. PubMed ID: 6765543 [TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy. Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896 [TBL] [Abstract][Full Text] [Related]
12. [Desensitization to human recombinant DNA insulin in an adolescent with insulin-dependent diabetes mellitus]. Rosas Vargas MA; Alvarez Amador M; Alvarez Amador LM; del Río Navarro BE; Avila Castanón L; Sienra Monge JJ Rev Alerg Mex; 2001; 48(5):129-32. PubMed ID: 11759253 [TBL] [Abstract][Full Text] [Related]
13. [Insulin allergy: background, diagnosis and treatment]. Wonders J; Eekhoff EM; Heine R; Bruynzeel DP; Rustemeyer T Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2783-8. PubMed ID: 16385830 [TBL] [Abstract][Full Text] [Related]
14. Development of IgE antibodies to human (recombinant DNA), porcine, and bovine insulins in diabetic subjects. Fireman P; Fineberg SE; Galloway JA Diabetes Care; 1982; 5 Suppl 2():119-25. PubMed ID: 6765521 [TBL] [Abstract][Full Text] [Related]
15. The U.S. "new patient" and "transfer" studies. Galloway JA; Peck FB; Fineberg SE; Spradlin CT; Marsden JH; Allemenos D; Ingulli-Fattic J Diabetes Care; 1982; 5 Suppl 2():135-9. PubMed ID: 6765525 [TBL] [Abstract][Full Text] [Related]
16. [Chronic insulin urticaria. Therapeutic efficacy and good tolerability of human insulins]. Mirouze J; Monnier L; Rodier M; Balducchi JP; Orsetti A; Clot J Nouv Presse Med; 1982 Oct; 11(42):3121-4. PubMed ID: 6757860 [TBL] [Abstract][Full Text] [Related]
17. Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient. Silva ME; Mendes MJ; Ursich MJ; Rocha DM; Brito AH; Fukui RT; Ruggeri GB; Nery M; Wajchenberg BL Diabetes Res Clin Pract; 1997 May; 36(2):67-70. PubMed ID: 9229189 [TBL] [Abstract][Full Text] [Related]
18. Crossover study with human insulin (recombinant DNA) in type I diabetic subjects. Landgraf R; Kammerer S; Bock T; Smolka B; Ladik T; Enzmann F; Landgraf-Leurs MM Diabetes Care; 1982; 5 Suppl 2():39-42. PubMed ID: 6765538 [TBL] [Abstract][Full Text] [Related]
19. Insulin-specific IgG and IgE antibody response in type I diabetic subjects exclusively treated with human insulin (recombinant DNA). Velcovsky HG; Federlin KF Diabetes Care; 1982; 5 Suppl 2():126-8. PubMed ID: 6765522 [TBL] [Abstract][Full Text] [Related]
20. Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergy. Kawasaki F; Kamei S; Tatsumi F; Hamamoto S; Shimoda M; Tawaramoto K; Shigeto M; Kanda Y; Hashiramoto M; Matsuki M; Kaku K Intern Med; 2009; 48(17):1545-9. PubMed ID: 19721301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]